Human OSCC TW2.6 (TW2.6/LOXL2) cells overexpressing LOXL2 exhibit enhanced migration, invasion, epithelial-mesenchymal transition (EMT), and cancer stem cell (CSC) phenotypes. Here, LOXL2 is linked to cancer.